Exploring Treatment Advances in Epilepsy: Keys to Optimizing Adherence and Patient Outcomes

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session from the 2018 Spring Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from August 15, 2018 to August 15, 2019

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by educational grants from
Eisai and UCB

Epilepsy is a chronic neurological disorder where the nerve cell activity in the brain becomes disrupted, causing seizures or periods of unusual behavior. Epilepsy affects about 3 million people in the United States and accounts for about $15 billion in medical costs. The diagnosis of epileptic seizures is made by analyzing the patient's clinical history as well as performing neurophysiological and neuroimaging tests. Treatment of epilepsy involves reducing the number of seizures by administering various antiepileptic drugs (AEDs). This approach requires long-term adherence from patients. Uncontrolled seizures and their associated comorbidities, such as depression, can have detrimental effects on the patient’s quality of life. The development of new AEDs continues to increase and drug therapies can now be individualized to the patient’s symptoms and needs. It is also important to understand the mechanisms of action and the pharmacokinetics of antiepileptic drugs so that these agents can be used effectively in clinical practice, especially in the combined therapeutic strategies.

Upon completion of this activity, participants will be able to:

  • Analyze the evidence-based approaches in the safety and efficacy of therapeutic regimens that achieve eliminating seizures while minimizing adverse effects

  • Identify the challenges associated with the diagnosis and management of seizures in patients with epilepsy, including the importance of video-EEG monitoring

  • Integrate recent clinical trial data and strategies into current and emerging therapies for the treatment of epilepsy

  • Discuss strategies to identify important comorbidities of epilepsy and their impact on patient quality of life

  • Examine the importance of optimizing treatment of seizures early in the epilepsy treatment trajectory in order to maximize tolerability and patient adherence

Faculty: Carl W. Bazil, MD, PhD
Caitlin Tynan Doyle Professor of Neurology at CPMC
Director, Division of Epilepsy and Sleep
Columbia University College of Physicians and Surgeons


Dr. Bazil previously served as a consultant for Purdue Pharma and UCB Pharma. Those relationships were terminated at least 12 months ago. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This presentation is supported by educational grants from
Eisai and UCB

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue